Targeting microRNAs in obesity
Author(s)
Xie, Huangming; Sun, Lei; Lodish, Harvey F
DownloadLodish_Targeting microRNAs.pdf (685.9Kb)
OPEN_ACCESS_POLICY
Open Access Policy
Creative Commons Attribution-Noncommercial-Share Alike
Terms of use
Metadata
Show full item recordAbstract
Obesity is a serious health problem worldwide associated with an increased risk of life-threatening diseases such as type 2 diabetes, atherosclerosis, and certain types of cancer. Fundamental for the development of novel therapeutics for obesity and its associated metabolic syndromes is an understanding of the regulation of fat cell development. Recent computational and experimental studies have shown that microRNAs (miRNAs) play a role in metabolic tissue development, lipid metabolism and glucose homeostasis. In addition, many miRNAs are dysregulated in metabolic tissues from obese animals and humans, which potentially contributes to the pathogenesis of obesity-associated complications. In this review we summarize the current state of understanding of the roles of miRNAs in metabolic tissues under normal development and obese conditions, and discuss the potential use of miRNAs as therapeutic targets.
Description
Author Manuscript 2011 October 20.
Date issued
2009-10Department
Massachusetts Institute of Technology. Department of Biological Engineering; Massachusetts Institute of Technology. Department of Biology; Massachusetts Institute of Technology. Department of ChemistryJournal
Expert Opinion on Therapeutic Targets
Publisher
Informa Healthcare
Citation
Xie, Huangming, Lei Sun, and Harvey F Lodish. “Targeting microRNAs in Obesity.” Expert Opinion on Therapeutic Targets 13.10 (2009): 1227–1238.
Version: Author's final manuscript
ISSN
1744-7631
1472-8222